Intellectual Property Watch

European Council conclusions on steps to combat antimicrobial resistance

The 28 European Union member governments have concluded next steps for addressing antimicrobial resistance, with a strong emphasis on reducing use of antibiotics in animals, but also including a call for new business models.

Read More →

MSF: AstraZeneca pullout of neglected disease R&D proof system broken

Following news reports that British pharmaceutical producer AstraZeneca will end its spending on early stage research and development for tuberculosis, malaria and neglected tropical diseases, Médecins Sans Frontières issued a statement saying the move is further proof that substantive change to the global pharmaceutical R&D system is needed.

Read More →

Successful WHO drug prequalification programme deemed at risk

A 12-year-old World Health Organization programme for prequalifying medical products has helped international organisations and others to safely purchase billions of US dollars’ worth of quality medicines per year, but now is at risk due to funding shortages, a new study released today found.

Read More →

US, WIPO IP summit in Africa postponed

A training programme on intellectual property organised by the United States with several partners to be held in Africa in April has been postponed under pressure to make the programme more transparent and representative of all stakeholders.

Read More →

Page 1 of 1 · Total posts: 4